SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

PHOSPHAGENICS LIMITED (POH)

Former Name ASX

Former (or subsequent) names

Shareholder links

Our website ranking of POH: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare, Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

Address: Unit A8, 2A Westall Road Clayton Victoria 3168
Tel:  +61 3 9002 5000 Fax: +61 3 9565 1151

Date first listed: 09/08/1993
Company Secretary: Melanie Leydin, Michael Sapountzis
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Pharmaceutical and nutraceutical company with a diversified portfolio of technologies encompassing drug delivery, drug enhancement, and active ingredients for dietary supplements, functional foods and personal care products

name changed to Avecho Biotechnology Limited

27/05/2019

The company announces that a full and final settlement of all claims associated with the arbitration has been successfully negotiated with Phosphagenics (POH), Mylan Laboratories Ltd (Mylan) and Strides Pharma Asia PTE Limited (Strides)

19/12/2018

The suspension of trading in the securities of Phosphagenics Limited ("˜POH') will be lifted immediately, following the release of an announcement by the Company.

19/12/2018

The company is continuing with advanced negotiations with Mylan in relation to the quantum of costs that might be payable under the arbitration and future arrangements for commercialisation of the intellectual property that has been under dispute. Accordingly the Company will remain in trading suspension until it announces finalisation of the agreements which are expected to be concluded by 14 December 2018.

13/12/2018

The securities of Phosphagenics Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of POH, pending the release of an announcement regarding Mylan arbitration cost negotiations.

12/12/2018

name changed from Vital Capital Limited

10/02/2004

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    02/03/2017David Segal500,000$0.020$10,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Greg CollierNon Exec Chairman13/04/2015
    Melanie LeydinCFO28/12/2018
    Ross MurdochNon Exec Director14/01/2015
    David SegalNon Exec Director19/05/2016
    Harry RosenDirector07/06/1999

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Anna LeggCFO22/01/201324/12/2018
    Peter LankauIndependent Director13/04/201525/05/2018
    Geert CauwenberghIndependent Director03/03/201430/05/2017
    Nathan DronaIndependent Director03/03/201418/05/2016
    Lawrence GozlanNon Exec Chairman, Independent Director03/03/201412/05/2015
    Jonathan AddisonChairman, Non Exec Director19/11/200203/03/2014
    Stuart JamesNon Exec Director24/08/201003/03/2014
    Sandra WebbNon Exec Director24/08/201003/03/2014
    Don ClarkeNon Exec Director24/08/201003/03/2014
    Esra OgruCEO, Executive Director11/10/200518/07/2013

    Date of first appointment, title may have changed.